Abstract
Estrogen-dependent osteoarthritis (EDPOA) is a disease of perimenopausal-age women. Their manifestations are polyarticular pain with common co-morbidities (carpal tunnel syndrome, insomnia, fatigue, depression, and fibromyalgia). Based on dual role of glucocorticoids, its trophic action on the chondrocyte and its anti-inflammatory effect, we conducted a prospective interventional cohort study where we evaluate the efficacy and safety of oral low-dose GC in one hundred women with EDPOA. The pain intensity, number of tender joints as well as impact in co-morbidities were analyzed. We conclude that the use of low-dose GC in patients with EDPOA can be an effective and a safe therapeutic option.
Original language | English |
---|---|
Pages (from-to) | 733-735 |
Number of pages | 3 |
Journal | Rheumatology International |
Volume | 34 |
Issue number | 5 |
DOIs | |
State | Published - May 2014 |
Externally published | Yes |
Keywords
- Glucocorticoids
- Menopause
- Primary osteoarthritis
- Steroids